אקסמסטאן אקטביס 25 מג
devries & co. ltd - exemestane - טבליות מצופות פילם - exemestane 25 mg - exemestane
ניאוטיגאזון 25 מג
abic marketing ltd, israel - acitretin - קפסולות - acitretin 25 mg - acitretin - acitretin - severe disorders of keratinization such as erythrodermic psoriasis local or generalized pustular psoriasis congenital ichthyosis pityriasis rubra pilaris darier's disease.
ניאוטיגאזון 10 מג
abic marketing ltd, israel - acitretin - קפסולות - acitretin 10 mg - acitretin
ניאוטיגאזון 25 מג
abic marketing ltd, israel - acitretin - קפסולות - acitretin 25 mg - acitretin
ניאוטיגאזון 10 מג
abic marketing ltd, israel - acitretin - קפסולות - acitretin 10 mg - acitretin - acitretin - severe disorders of keratinization such as erythrodermic psoriasis local or generalized pustular psoriasis congenital ichthyosis pityriasis rubra pilaris darier's disease.
סיל - און 25
rafa laboratories ltd - sildenafil 25 mg - film coated tablets - sildenafil - treatment of erectile dysfunction.
סיל - און 50
rafa laboratories ltd - sildenafil 50 mg - film coated tablets - sildenafil - treatment of erectile dysfunction.
סיל - און 100
rafa laboratories ltd - sildenafil 100 mg - film coated tablets - sildenafil - treatment of erectile dysfunction.
ציטוסאר 100
pfizer pharmaceuticals israel ltd - cytarabine 100 mg / 5 ml - powder for solution for inj/inf - cytarabine - for leukemia.
ג'מסיטאבין אקטביס 200 מ"ג/בקבוקון
devries & co. ltd - gemcitabine 200 mg/vial - powder for solution for infusion - gemcitabine - gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer in combination with cisplatin. gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas.gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc). gemcitabine monotherapy can be considered in elderly patients or those with performance status 2. gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelial ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum-based, first-line therapy. gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherap